These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26617740)

  • 1. Overexpression of histone demethylase JMJD5 promotes metastasis and indicates a poor prognosis in breast cancer.
    Zhao Z; Sun C; Li F; Han J; Li X; Song Z
    Int J Clin Exp Pathol; 2015; 8(9):10325-34. PubMed ID: 26617740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
    Olmeda D; Moreno-Bueno G; Flores JM; Fabra A; Portillo F; Cano A
    Cancer Res; 2007 Dec; 67(24):11721-31. PubMed ID: 18089802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
    Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
    J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soybean (Glycine max) prevents the progression of breast cancer cells by downregulating the level of histone demethylase JMJD5.
    Wang Y; Liu L; Ji F; Jiang J; Yu Y; Sheng S; Li H
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S609-S615. PubMed ID: 30249876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic TMEM88 promotes triple-negative breast cancer by interacting with Dvl.
    Yu X; Zhang X; Zhang Y; Jiang G; Mao X; Jin F
    Oncotarget; 2015 Sep; 6(28):25034-45. PubMed ID: 26325443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
    Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
    Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
    Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
    Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS
    Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Shin NR; Jeong EH; Choi CI; Moon HJ; Kwon CH; Chu IS; Kim GH; Jeon TY; Kim DH; Lee JH; Park DY
    BMC Cancer; 2012 Nov; 12():521. PubMed ID: 23151184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin promotes the progression and metastasis of breast cancer through the regulation of epithelial‑mesenchymal transition via the p38/GSK3β pathway.
    Han Y; Zhang L; Wang W; Li J; Song M
    Oncol Rep; 2017 Dec; 38(6):3574-3582. PubMed ID: 29039608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JMJD5 is a potential oncogene for colon carcinogenesis.
    Zhang R; Huang Q; Li Y; Song Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(6):6482-9. PubMed ID: 26261525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CXCL14 and its anticancer role in breast cancer.
    Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.